A Rigotti

Summary

Country: Chile

Publications

  1. ncbi [Intensive cholesterol lowering therapy to reduce cardiovascular risk]
    Attilio Rigotti R
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Med Chil 134:641-8. 2006
  2. ncbi Scavenger receptors and atherosclerosis
    A Rigotti
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    Biol Res 33:97-103. 2000
  3. ncbi Absorption, transport, and tissue delivery of vitamin E
    Attilio Rigotti
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Hospital UC, Marcoleta 367, Santiago, Chile
    Mol Aspects Med 28:423-36. 2007
  4. ncbi Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium
    J F Miquel
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Marcoleta 367, Santiago, Chile
    Gut 52:1017-24. 2003
  5. ncbi Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat
    F Nervi
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    J Clin Invest 82:1818-25. 1988
  6. ncbi Biliary lipid secretion: immunolocalization and identification of a protein associated with lamellar cholesterol carriers in supersaturated rat and human bile
    A Rigotti
    Departamento de Gastroenterologia, Pontificia Universidad Catolica, Santiago, Chile
    J Lipid Res 34:1883-94. 1993
  7. ncbi Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet
    L Amigo
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    Gastroenterology 118:772-9. 2000
  8. ncbi Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world
    P Margozzini
    Departamento de Salud Publica, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Marcoleta 434, Santiago, Chile
    Ther Adv Cardiovasc Dis 1:83-90. 2007
  9. ncbi Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
    Flavio Nervi
    Departmento de Gastroenterologia, Pontificia Universidad Catolica de Chile, 367 Marcoleta, Casilla 114 D, Santiago, Chile
    J Hepatol 45:299-305. 2006
  10. ncbi [The metabolic syndrome: from an aggravating condition to a pathogenic risk factor for chronic diseases]
    Rommy von Bernhardi
    Departamento de Neurologia, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Med Chil 138:1012-9. 2010

Collaborators

  • Flavio Nervi
  • J F Miquel
  • M Arrese
  • M Krieger
  • M Schwarz
  • I I Wistuba
  • B Trigatti
  • D E Cohen
  • G Mingrone
  • B Staels
  • Alejandro Soza
  • Antonio Arteaga
  • J Rozowski
  • Catterina Ferreccio
  • Luis Villarroel
  • Olivier N Kocher
  • David Q H Wang
  • Arnoldo Riquelme
  • Silvana Zanlungo
  • Pablo Mardones
  • Ludwig Amigo
  • Ada Cuevas
  • Ayce Yesilaltay
  • L Amigo
  • Maria Gabriela Morales
  • Rommy von Bernhardi
  • Sara A Fenske
  • P Margozzini
  • Juan G Mella
  • Rinku Pal
  • Ignacio Bravo
  • P Mardones
  • Attilio Rigotti R
  • Nora Morgado
  • Patricia V Burgos
  • Veronica Quinones
  • Marcela Altayo
  • V Quinones
  • Hector Molina
  • Mariana Acuña
  • Elisa Balboa
  • Juan Castro
  • Guillermo Marshall
  • Alfredo Molina
  • Kathleen Daniels
  • Soledad Reyes
  • Frank Lammert
  • M Garrido
  • Omar Francone
  • Hermann E Wasmuth
  • Ramin Schirin-Sokhan
  • G Valdes
  • N Quezada
  • Tilman Sauerbruch
  • Fernando Pimentel
  • Antonio Arteaga Ll
  • Alberto Maiz G
  • Andrea Leiva
  • Alfonso Valenzuela
  • Veronica Alvarez
  • Joaquín Montero
  • Carla Klattenhoff
  • Erwin de la Fuente
  • Ana Maria Acosta
  • Hiroyuki Arai
  • Antoine Pilon
  • Muriel Bouly
  • Veronique Clavey
  • Gerald Luc
  • Carla Ferrada
  • Karen F Kozarsky
  • Takako Nishimoto
  • Daniel Duran
  • Pablo Strobel
  • Federico Leighton
  • J Chianale
  • Soledad Miranda
  • M Moreno
  • H E Miettinen
  • S VanPatten
  • S Zanlungo
  • M Pizarro
  • L Nunez
  • L Accatino
  • A M Wielandt
  • S Gonzalez
  • V Vollrath
  • L Andrade
  • L Puglielli
  • A V Greco

Detail Information

Publications32

  1. ncbi [Intensive cholesterol lowering therapy to reduce cardiovascular risk]
    Attilio Rigotti R
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Med Chil 134:641-8. 2006
    ..An effective reduction of serum cholesterol can be obtained using statins in high doses or a combination of hypolipidemic drugs with different mechanisms of action...
  2. ncbi Scavenger receptors and atherosclerosis
    A Rigotti
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    Biol Res 33:97-103. 2000
    ..Recent in vitro and in vivo studies strongly support the role of class A and class B scavenger receptors in lipid transport and atherogenesis...
  3. ncbi Absorption, transport, and tissue delivery of vitamin E
    Attilio Rigotti
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Hospital UC, Marcoleta 367, Santiago, Chile
    Mol Aspects Med 28:423-36. 2007
    ..This new information may be critical for manipulation of vitamin E homeostasis in a variety of oxidative stress-related disease conditions in humans...
  4. ncbi Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium
    J F Miquel
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Marcoleta 367, Santiago, Chile
    Gut 52:1017-24. 2003
    ....
  5. ncbi Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat
    F Nervi
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    J Clin Invest 82:1818-25. 1988
    ....
  6. ncbi Biliary lipid secretion: immunolocalization and identification of a protein associated with lamellar cholesterol carriers in supersaturated rat and human bile
    A Rigotti
    Departamento de Gastroenterologia, Pontificia Universidad Catolica, Santiago, Chile
    J Lipid Res 34:1883-94. 1993
    ..The identification of aminopeptidase N associated with biliary lamellae is consistent with the involvement of the canalicular membrane in the secretory mechanism of biliary lipids...
  7. ncbi Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet
    L Amigo
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    Gastroenterology 118:772-9. 2000
    ..To test this hypothesis, we studied biliary lipid secretion and gallstone formation in apoE-deficient mice fed cholesterol-rich diets...
  8. ncbi Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world
    P Margozzini
    Departamento de Salud Publica, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Marcoleta 434, Santiago, Chile
    Ther Adv Cardiovasc Dis 1:83-90. 2007
    ..We illustrate this situation analyzing hypertension and cardiometabolic syndrome data derived from a recent national health survey in Chile...
  9. ncbi Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
    Flavio Nervi
    Departmento de Gastroenterologia, Pontificia Universidad Catolica de Chile, 367 Marcoleta, Casilla 114 D, Santiago, Chile
    J Hepatol 45:299-305. 2006
    ..We tested whether cholesterol gallstone disease (GS) is associated to insulin resistance and serum C-reactive protein (CRP) in a high risk population...
  10. ncbi [The metabolic syndrome: from an aggravating condition to a pathogenic risk factor for chronic diseases]
    Rommy von Bernhardi
    Departamento de Neurologia, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Med Chil 138:1012-9. 2010
    ..The development of new therapeutic and preventive strategies for these diseases will be a corollary of this research...
  11. ncbi Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice
    P Mardones
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    J Lipid Res 42:170-80. 2001
    ..In contrast, SR-BI expression is not essential for intestinal cholesterol absorption...
  12. ncbi Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics
    Arnoldo Riquelme
    Departamentos de Gastroenterología, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Liver Int 29:82-8. 2009
    ..Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder of the liver, which may progress to fibrosis or cirrhosis. Recent studies have shown a significant impact of ethnicity on susceptibility to steatosis-related liver disease...
  13. ncbi Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations
    Juan G Mella
    Departamento de Gastroenterologia, Pontificia Universidad Catolica de Chile, Santiago, Chile
    J Lipid Res 48:1378-85. 2007
    ..In contrast to previous smaller studies, apoE polymorphisms were not associated with susceptibility to cholesterol GD in high-risk populations...
  14. ncbi The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues
    Attilio Rigotti
    , Facultad de Medicina, , Santiago, Chile
    Endocr Rev 24:357-87. 2003
    ..If SR-BI plays similar physiological and pathophysiological roles in humans, it may be an attractive target for therapeutic intervention in cardiovascular and reproductive diseases...
  15. ncbi Cholesterol crystallization-promoting activity of aminopeptidase-N isolated from the vesicular carrier of biliary lipids
    L Nunez
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    FEBS Lett 329:84-8. 1993
    ..Because of this promoting effect on in vitro cholesterol crystal formation, we suggest that biliary aminopeptidase-N may play a critical role in the pathogenesis of cholesterol gallstone disease...
  16. ncbi Hepatic cholesterol transport from plasma into bile: implications for gallstone disease
    Silvana Zanlungo
    Department of Gastroenterology, Faculty of Medicine, Pontifical Catholic University of Chile, Marcoleta 367, Santiago, Chile
    Curr Opin Lipidol 15:279-86. 2004
    ..These advances may provide new avenues for prevention and treatment of various disease conditions linked to abnormal cholesterol metabolism...
  17. ncbi Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice
    Pablo Mardones
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    J Nutr 132:443-9. 2002
    ..Defective tissue uptake of lipoprotein alpha-T in SR-BI-deficient mice may contribute to the reproductive and cardiovascular pathologies exhibited by these animals...
  18. ncbi Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
    J Chianale
    Departamento de Gastroenterologia, Pontificia Universidad Catolica de Chile, Santiago
    Biochem J 314:781-6. 1996
    ....
  19. ncbi [Mechanisms of hypo and hyper alphalipoproteinemia in Chilean adults]
    Ada Cuevas
    Departamento de Nutricion, Diabetes y Metabolismo, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Rev Med Chil 132:421-8. 2004
    ..Disturbances in HDL cholesterol plasma levels are frequent in the Chilean population, however the pathophysiological mechanisms are unknown...
  20. ncbi Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice
    Maria Gabriela Morales
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile
    Liver Int 30:887-97. 2010
    ....
  21. ncbi Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease
    Pablo Mardones
    , Facultad de Medicina, , Marcoleta 367, Santiago, Chile
    J Nutr Biochem 15:252-60. 2004
    ..This review is mainly focused on the role of the scavenger receptor class B type I (SR-BI) on alpha-tocopherol metabolism and its potential implications for disease conditions...
  22. ncbi Trends in obesity and diabetes prevalence in a Chilean urban population: 1993-2001
    Ada Cuevas
    Centro de Nutrición y Obesidad, Clinica Las Condes, Santiago, Chile
    Metab Syndr Relat Disord 6:219-22. 2008
    ..We aimed to assess diabetes mellitus, obesity, and hypercholesterolemia trends in a Chilean urban population followed between 1993 and 2001...
  23. ncbi Cholesterol depletion induces PKA-mediated basolateral-to-apical transcytosis of the scavenger receptor class B type I in MDCK cells
    Patricia V Burgos
    , , , , Santiago 6510260, Chile
    Proc Natl Acad Sci U S A 101:3845-50. 2004
    ..These results disclose relationships between cholesterol-based rafts and PKA activity operating in a post-TGN mechanism of regulated apical-to-basolateral cell surface protein distribution...
  24. ncbi Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice
    Ludwig Amigo
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica, Santiago, Chile
    Hepatology 38:726-34. 2003
    ..In conclusion, the deficiency of HL has no major impact on the availability of lipoprotein-derived hepatic cholesterol for biliary secretion; HL expression is not essential for diet-induced gallstone formation in mice...
  25. ncbi Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice
    Pablo Mardones
    Departamento de Gastroenterologia, Facultad de Medicina, , Marcoleta 367, Santiago, Chile
    J Biol Chem 278:7884-90. 2003
    ..This study describes a novel effect of fibrates on hepatic SR-BI expression providing an alternative mechanism by which this drug family modulates HDL metabolism in vivo...
  26. ncbi Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis
    Bernardo L Trigatti
    Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada
    Arterioscler Thromb Vasc Biol 23:1732-8. 2003
    ..Remarkably, SR-BI/apolipoprotein E double-knockout mice develop complex coronary artery disease, myocardial infarction, and heart failure. Additional studies should help to define the importance of SR-BI in human health and disease...
  27. ncbi Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism
    Olivier Kocher
    Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    J Biol Chem 278:52820-5. 2003
    ..The PDZK1-dependent regulation of hepatic SR-BI and, thus, lipoprotein metabolism supports the proposal that this adaptor may represent a new target for therapeutic intervention in cardiovascular disease...
  28. ncbi PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function
    Ayce Yesilaltay
    Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    J Biol Chem 281:28975-80. 2006
    ..Thus, PDZK1 is important for maintaining adequate steady state levels of SR-BI in the liver but is not essential for cell surface expression or function of hepatic SR-BI...
  29. ncbi Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization
    Sara A Fenske
    Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    J Biol Chem 283:22097-104. 2008
    ....
  30. ncbi HDL receptor SR-BI and cholesterol gallstones
    Attilio Rigotti
    Hepatology 35:240-2. 2002
  31. ncbi Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat
    Nora Morgado
    Laboratorio de Lípidos y Antioxidantes, INTA, Universidad de Chile, Santiago
    Ann Nutr Metab 49:397-406. 2005
    ..On the other hand, omega-3 PUFAs decrease plasma HDL levels compared to other fatty acids, which may suggest an effect on reverse cholesterol transport...
  32. ncbi Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse
    Ignacio Bravo
    Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Marcoleta 367, Casilla 114 D, Santiago, Chile, and Brigham and Women s Hospital, Boston, MA 02115, USA
    Biochim Biophys Acta 1770:979-88. 2007
    ....